logo

Corcept Therapeutics Inc (CORT)



Trade CORT now with
  Date
  Headline
9/17/2021 8:48:29 AM Corcept Presents Positive Results From Phase 2 Trial Of Relacorilant On Ovarian Cancer
6/10/2021 7:34:01 AM Corcept Therapeutics Appoints Joshua Murray To Board
9/10/2020 8:41:45 AM Corcept Therapeutics Begins Second Phase 2 Trial Of Miricorilant To Treat Weight Gain Caused By Antipsychotic Medication
7/28/2020 8:39:47 AM Corcept Therapeutics Enrolls First Patient In GRADIENT Phase 3 Trial Of Relacorilant